======= MAGI2 ======= == Gene Information == * **Official Symbol**: MAGI2 * **Official Name**: membrane associated guanylate kinase, WW and PDZ domain containing 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9863|9863]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q86UL8|Q86UL8]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MAGI2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MAGI2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/606382|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene interacts with atrophin-1. Atrophin-1 contains a polyglutamine repeat, expansion of which is responsible for dentatorubral and pallidoluysian atrophy. This encoded protein is characterized by two WW domains, a guanylate kinase-like domain, and multiple PDZ domains. It has structural similarity to the membrane-associated guanylate kinase homologue (MAGUK) family. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: N/A |Guanylate kin| |PDZ| |WW| |type II activin receptor binding| |beta-1 adrenergic receptor binding| |neuroligin clustering involved in postsynaptic membrane assembly| |planar cell polarity pathway involved in axis elongation| |positive regulation of synaptic vesicle clustering| |regulation of synaptic vesicle clustering| |slit diaphragm| |glomerular visceral epithelial cell development| |glomerular epithelial cell development| |negative regulation of activin receptor signaling pathway| |nerve growth factor signaling pathway| |postsynaptic membrane assembly| |renal filtration cell differentiation| |glomerular visceral epithelial cell differentiation| |mitotic cell cycle arrest| |glomerular epithelial cell differentiation| |postsynapse assembly| |glomerular epithelium development| |positive regulation of phosphoprotein phosphatase activity| |receptor signaling complex adaptor activity| |regulation of activin receptor signaling pathway| |positive regulation of receptor internalization| |axis elongation| |neurotrophin signaling pathway| |postsynaptic membrane organization| |epithelial cell differentiation involved in kidney development| |positive regulation of phosphatase activity| |membrane assembly| |membrane biogenesis| |cell differentiation involved in kidney development| |positive regulation of protein dephosphorylation| |negative regulation of protein kinase B signaling| |receptor clustering| |cellular response to nerve growth factor stimulus| |phosphatase binding| |glomerulus development| |positive regulation of receptor-mediated endocytosis| |response to nerve growth factor| |SMAD binding| |regulation of receptor internalization| |SMAD protein signal transduction| |positive regulation of dephosphorylation| |localization within membrane| |postsynapse organization| |synapse assembly| |nephron epithelium development| |Wnt signaling pathway, planar cell polarity pathway| |regulation of receptor-mediated endocytosis| |positive regulation of endocytosis| |protein heterooligomerization| |regulation of establishment of planar polarity| |regulation of synaptic vesicle cycle| |developmental growth involved in morphogenesis| |negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway| |regulation of phosphoprotein phosphatase activity| |bicellular tight junction| |nephron development| |late endosome| |kidney epithelium development| |non-canonical Wnt signaling pathway| |regulation of protein dephosphorylation| |cell cycle arrest| |cell-cell junction| |regulation of phosphatase activity| |regulation of morphogenesis of an epithelium| |epithelial cell development| |transmembrane receptor protein serine/threonine kinase signaling pathway| |regulation of endocytosis| |regulation of dephosphorylation| |regulation of protein kinase B signaling| |regulation of transmembrane receptor protein serine/threonine kinase signaling pathway| |postsynaptic density| |regulation of animal organ morphogenesis| |negative regulation of cell migration| |kidney development| |synapse| |synapse organization| |negative regulation of cell motility| |positive regulation of neuron projection development| |renal system development| |negative regulation of mitotic cell cycle| |negative regulation of cellular component movement| |urogenital system development| |negative regulation of locomotion| |Wnt signaling pathway| |cell-cell signaling by wnt| |positive regulation of neuron differentiation| |positive regulation of cell projection organization| |developmental growth| |growth| |dendrite| |cell surface receptor signaling pathway involved in cell-cell signaling| |positive regulation of neurogenesis| |protein localization to membrane| |regulation of neuron projection development| |cellular response to growth factor stimulus| |negative regulation of intracellular signal transduction| |protein complex oligomerization| |response to growth factor| |positive regulation of nervous system development| |positive regulation of cell development| |regulation of vesicle-mediated transport| |negative regulation of cell cycle| |protein-containing complex| |regulation of mitotic cell cycle| |regulation of neuron differentiation| |negative regulation of cell population proliferation| |epithelial cell differentiation| |regulation of plasma membrane bounded cell projection organization| |perinuclear region of cytoplasm| |regulation of cell projection organization| |enzyme linked receptor protein signaling pathway| |positive regulation of hydrolase activity| |regulation of neurogenesis| |regulation of cell migration| |membrane organization| |regulation of cell motility| |regulation of cellular localization| |regulation of nervous system development| |regulation of cell development| |positive regulation of cell differentiation| |regulation of locomotion| |positive regulation of transport| |regulation of cellular component movement| |cell cycle process| |regulation of anatomical structure morphogenesis| |epithelium development| |cell-cell signaling| |positive regulation of phosphate metabolic process| |positive regulation of phosphorus metabolic process| |regulation of cell cycle| |positive regulation of cellular component organization| |cellular response to endogenous stimulus| |positive regulation of protein modification process| |negative regulation of signal transduction| |regulation of hydrolase activity| |cell cycle| |negative regulation of cell communication| |negative regulation of signaling| |positive regulation of developmental process| |positive regulation of catalytic activity| |response to endogenous stimulus| |generation of neurons| |protein-containing complex assembly| |cellular protein localization| |cellular macromolecule localization| |positive regulation of cellular protein metabolic process| |regulation of cell population proliferation| |negative regulation of response to stimulus| |neurogenesis| |cell development| |positive regulation of signal transduction| |positive regulation of protein metabolic process| |positive regulation of multicellular organismal process| |tissue development| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of cell differentiation| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| |protein-containing complex subunit organization| |regulation of transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp473|Cincreasin 100μM R08 exp473]]|-1.85| |[[:results:exp533|TNF-alpha 44ng/ml R08 exp533]]|-1.85| |[[:results:exp336|Asunaprenir 3μM R07 exp336]]|-1.84| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6947 * **Expression level (log2 read counts)**: 1.84 {{:chemogenomics:nalm6 dist.png?nolink |}}